Oki Mark K
CIK 0001491847
Chief Financial Officer
Filings
7
Latest Jan 30, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -50.9% | -50.9% | -27.5% | -74.2% |
| 90 days | 2 | 50% | -20.4% | -20.4% | +6.5% | -47.4% |
| 180 days | 2 | 50% | -21.8% | -21.8% | +4.5% | -48.1% |
| 365 days | 1 | 100% | +46.0% | +46.0% | +46.0% | +46.0% |
Issuers
Companies where Oki Mark K has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACHV | Achieve Life Sciences, Inc. | 5 | Jan 30, 2026 |
| AYTU | Aytu Biopharma, Inc | 2 | Aug 15, 2023 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|